These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8637631

  • 21. Expression of GFAP in the striatum and its projection areas in response to striatal quinolinic acid lesion in rats.
    Block F, Schwarz M.
    Neuroreport; 1994 Nov 21; 5(17):2237-40. PubMed ID: 7881035
    [Abstract] [Full Text] [Related]

  • 22. Energetic dysfunction in quinolinic acid-lesioned rat striatum.
    Bordelon YM, Chesselet MF, Nelson D, Welsh F, Erecińska M.
    J Neurochem; 1997 Oct 21; 69(4):1629-39. PubMed ID: 9326292
    [Abstract] [Full Text] [Related]

  • 23. Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors.
    Johansson B, Georgiev V, Fredholm BB.
    Neuroscience; 1997 Oct 21; 80(4):1187-207. PubMed ID: 9284070
    [Abstract] [Full Text] [Related]

  • 24. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
    Hughes PE, Alexi T, Williams CE, Clark RG, Gluckman PD.
    Neuroscience; 1999 Oct 21; 92(1):197-209. PubMed ID: 10392842
    [Abstract] [Full Text] [Related]

  • 25. Striatal quinolinic acid lesions increase [3H]WIN 35,428 binding to the dopamine transporter.
    Gehlert DR, Schoepp DD.
    Neurochem Int; 1992 Dec 21; 21(4):581-4. PubMed ID: 1303740
    [Abstract] [Full Text] [Related]

  • 26. Adenosine A2 receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats.
    Morelli M, Fenu S, Pinna A, Di Chiara G.
    Eur J Pharmacol; 1994 Jan 04; 251(1):21-5. PubMed ID: 7907985
    [Abstract] [Full Text] [Related]

  • 27. Striatal implants protect the host striatum against quinolinic acid toxicity.
    Pearlman SH, Levivier M, Collier TJ, Sladek JR, Gash DM.
    Exp Brain Res; 1991 Jan 04; 84(2):303-10. PubMed ID: 1829685
    [Abstract] [Full Text] [Related]

  • 28. Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum.
    Ryu JK, Choi HB, McLarnon JG.
    Neurobiol Dis; 2005 Nov 04; 20(2):550-61. PubMed ID: 15916899
    [Abstract] [Full Text] [Related]

  • 29. SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices.
    Tebano MT, Domenici MR, Popoli P.
    Eur J Pharmacol; 2002 Aug 30; 450(3):253-7. PubMed ID: 12208317
    [Abstract] [Full Text] [Related]

  • 30. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease.
    Chen GJ, Jeng CH, Lin SZ, Tsai SH, Wang Y, Chiang YH.
    J Biomed Sci; 2002 Aug 30; 9(4):303-10. PubMed ID: 12145527
    [Abstract] [Full Text] [Related]

  • 31. Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
    Gill JS, Jamwal S, Kumar P, Deshmukh R.
    Pharmacol Rep; 2017 Apr 30; 69(2):306-313. PubMed ID: 28178592
    [Abstract] [Full Text] [Related]

  • 32. Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease.
    Gianfriddo M, Corsi C, Melani A, Pèzzola A, Reggio R, Popoli P, Pedata F.
    Brain Res; 2003 Jul 25; 979(1-2):225-9. PubMed ID: 12850590
    [Abstract] [Full Text] [Related]

  • 33. Long-term cortical atrophy after excitotoxic striatal lesion: effects of intrastriatal fetal-striatum grafts and implications for Huntington disease.
    Muñoz A, Lopez A, Caruncho HJ, Guerra MJ, Labandeira-García JL.
    J Neuropathol Exp Neurol; 2001 Aug 25; 60(8):786-97. PubMed ID: 11487053
    [Abstract] [Full Text] [Related]

  • 34. Intrastriatal infusion of nerve growth factor after quinolinic acid prevents reduction of cellular expression of choline acetyltransferase messenger RNA and trkA messenger RNA, but not glutamate decarboxylase messenger RNA.
    Venero JL, Beck KD, Hefti F.
    Neuroscience; 1994 Jul 25; 61(2):257-68. PubMed ID: 7969907
    [Abstract] [Full Text] [Related]

  • 35. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.
    Huang Q, Zhou D, Sapp E, Aizawa H, Ge P, Bird ED, Vonsattel JP, DiFiglia M.
    Neuroscience; 1995 Mar 25; 65(2):397-407. PubMed ID: 7777157
    [Abstract] [Full Text] [Related]

  • 36. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia.
    Bordelon YM, Chesselet MF.
    Neuroscience; 1999 Mar 25; 93(3):843-53. PubMed ID: 10473250
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.
    Wenning GK, Granata R, Laboyrie PM, Quinn NP, Jenner P, Marsden CD.
    Mov Disord; 1996 Sep 25; 11(5):522-32. PubMed ID: 8866493
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.